feed,title,long_url,short_url
Investing,"Traders celebrate Bitcoin's impending ETF, but options markets are less certain",https://investing.com/news/-2645686,
Investing,U.S. FDA declines to approve Revance's frown-line treatment,https://investing.com/news/-2645689,
